|Bid||38.50 x 0|
|Ask||40.00 x 0|
|Day's Range||38.00 - 40.00|
|52 Week Range||34.00 - 153.00|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 17, 2021 - May 21, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||70.00|
We feel now is a pretty good time to analyse Shield Therapeutics plc's ( LON:STX ) business as it appears the company...
Even if it's not a huge purchase, we think it was good to see that Timothy Watts, the CEO & Director of Shield...
Shield Therapeutics plc (LON:STX) shareholders will have a reason to smile today, with the analysts making substantial...